Administering Gonadotrophin Releasing Hormone (GnRH) Agonists during the Luteal Phase in Artificial Cycle Frozen-Thawed Embryo Transfers

Phase 3

Completed

• Conditions: Frozen Thawed embryo transfers in Assisted Reproduction Technology; Reproductive Health and Childbirth - Fertility including in vitro fertilisation

• Registration Number: ACTRN12614000715673
• Lead Sponsor: Hopital Femme Mere Enfant

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-07-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 220

Inclusion Criteria

All patients undergoing artificial cycle of Frozen Thawed Embryo Transfers in our Assisted Reproduction Technology' s center

Exclusion Criteria

Frozen Thawed Embryo Transfers resulting from oocyte or embryo donations

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome was the ongoing pregnacy rate. This was the number of pregnancies that continue beyond the first trimester obstetrical ultrasound, out of 100 Frozen Thawed Embryo Transfers. [The first trimester obstetrical ultrasound (around the 12th week on pregnancy)]

Secondary Outcome Measures

Name	Time	Method
The secondary outcome was the implantation rate. It was defined by the number of gestational sacs that contain embryos with cardiac activity, divided by the number of transferred embryos.[A obstrtrical ultrasound around 6 weeks of pregnancy ]